24 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified … , reputational harm, additional reporting obligations and oversight if we become subject to a corporate integrity agreement or other agreement
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight … , damages, fines, disgorgement, reputational harm, additional reporting obligations and oversight if we become subject to a corporate integrity agreement
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
to the Audit Committee, including the matters required to be discussed by the Public Company Accounting Oversight Board (“PCAOB”) and the SEC.
The Company’s … tend to receive repetitive or duplicative communications.
Board Leadership Structure and Role in Risk Oversight
Our Amended and Restated Bylaws
S-3
qkzx2q1 xzm
12 Nov 21
Shelf registration
12:00am
S-3
EX-1.2
4jghc3
12 Nov 21
Shelf registration
12:00am
DEF 14A
5yf iv260552w6v01
26 Apr 21
Definitive proxy
5:00pm
10-K
wsm8x
18 Mar 21
Annual report
6:31am
424B4
olxyjq
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
hcoh3rffl8gp vw
1 Feb 21
Draft registration statement
12:00am
10-Q
yqtjmn18w8bfz
10 Dec 20
Quarterly report
4:46pm
424B4
gslme dy787j0o5
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
i0dftwylwkos4xac
9 Oct 20
IPO registration
4:59pm
S-1
EX-10.7
cvgk0sriqiuf9f
9 Oct 20
IPO registration
4:59pm